2022
DOI: 10.2147/tcrm.s375064
|View full text |Cite
|
Sign up to set email alerts
|

Intracranial Solitary Fibrous Tumor/Hemangiopericytoma Treated with Microsurgical Resection: Retrospective Cohort Analysis of a Single-Center Experience

Abstract: To provide benchmarks for further studies of solitary fibrous tumor/hemangiopericytoma (SFT/HPC) of the central nervous system (CNS), we investigated the association of baseline demographic, clinico-pathologic, and treatment factors with outcomes in those treated at our center. Methods: We conducted a retrospective, cohort analysis of patients treated for SFT/HPC at the University of Washington 1990-2020. Kaplan-Meier and univariable Cox analyses assessed relationships between baseline variables and local or g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 26 publications
0
4
0
Order By: Relevance
“…Follow-up and monitoring of SFT are inevitable recommendations (51). According to the research, longterm persistence in follow-up is rare among patients.…”
Section: Follow-upmentioning
confidence: 99%
“…Follow-up and monitoring of SFT are inevitable recommendations (51). According to the research, longterm persistence in follow-up is rare among patients.…”
Section: Follow-upmentioning
confidence: 99%
“…The recent studies had reported that the incidence of this tumor is increasing, and it required specialized medical attention (Lu et al 2022 ). As the form of classification is updated, there is a lack of research on prognostic factors and outcomes for combined SFT and HPC tumors, with previous studies often limited by small sample sizes and an inability to validate findings (Swaminathan et al 2022a ; Mena et al 1991 ; Rutkowski et al 2012 ; Zeng et al 2017 ; Wu et al 2021 ). Moreover, there is inadequate description regarding the survival pattern of SFT/HPC patients in contemporary time.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, there is inadequate description regarding the survival pattern of SFT/HPC patients in contemporary time. The survival description of this tumor is often based on a relatively small sample size and is generally targeted at overall survival (OS) (Wu et al 2021 ; Swaminathan et al 2022b ). Further investigation is required to determine the conditional survival (CS) of SFT/HPC.…”
Section: Introductionmentioning
confidence: 99%
“…6,7 SFTs are primarily discovered in middle-aged patients, with a mean age of 44 years at presentation and no predilection regarding sex. 8…”
mentioning
confidence: 99%
“…6,7 SFTs are primarily discovered in middle-aged patients, with a mean age of 44 years at presentation and no predilection regarding sex. 8 In 2016, the World Health Organization (WHO) issued a designation combining SFTs and hemangiopericytomas (HPCs) into a single entity because of the sharing of genetic origins, a chromosomal inversion at the 12q13 locus leading to a NAB2:: STAT6 fusion product. 2,9,10 However, in the latest 2021 WHO Classification of Tumors of the CNS, the joint term "SFT/HPC" has been consolidated to "SFT."…”
mentioning
confidence: 99%